Serological biomarkers were evaluated in serum samples (n = 404) from repositories managed by the Foundation for Innovative New Diagnostics (FIND) TB to investigate the influence of HIV co‐infection and host factors on serological biomarkers, using anti‐A60 IgG and IgA and CRP as markers of TB. This evidence concerns the gene CD79A and tuberculosis.